Home > Boards > US Listed > Biotechs > KemPharm Inc. (KMPH)

I appreciate your opinion, I've made some money

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Muskyman3 Member Profile
 
Followed By 0
Posts 302
Boards Moderated 0
Alias Born 07/02/19
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/1/2021 4:29:30 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 12/1/2021 8:26:20 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/30/2021 4:11:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/23/2021 4:04:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/18/2021 4:58:25 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/10/2021 5:20:24 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/10/2021 5:16:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2021 5:13:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2021 4:14:27 PM
KemPharm EPS beats by $0.02, misses on revenue Seeking Alpha - 11/10/2021 4:10:48 PM
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates GlobeNewswire Inc. - 11/10/2021 4:05:00 PM
KemPharm Q3 2021 Earnings Preview Seeking Alpha - 11/9/2021 5:35:06 PM
KemPharm Announces AZSTARYS® Clinical Data to be Featured in Poster Presentation at the 2021 Virtual International Conference on ADHD GlobeNewswire Inc. - 11/5/2021 7:30:00 AM
KemPharm to Report Third Quarter 2021 Results GlobeNewswire Inc. - 11/3/2021 9:22:21 AM
AZSTARYS®, An Innovative ADHD Treatment Developed by KemPharm, to be Featured in a Poster Presentation at the 2021 Psych Congress GlobeNewswire Inc. - 10/27/2021 7:30:00 AM
KemPharm Announces Research Involving AZSTARYS® and Serdexmethylphenidate to be Featured in Poster Presentations at Multiple Medical Conferences during ADHD Awareness Month (October) GlobeNewswire Inc. - 10/20/2021 7:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/19/2021 9:28:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/19/2021 9:24:49 AM
KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market GlobeNewswire Inc. - 10/19/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/29/2021 4:11:46 PM
KemPharm to Present at the Benzinga Healthcare Small Cap Conference GlobeNewswire Inc. - 9/27/2021 7:30:00 AM
KemPharm to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/23/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/20/2021 5:03:46 PM
KemPharm to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2021 4:04:59 PM
Muskyman3   Tuesday, 08/03/21 05:54:13 PM
Re: doebop post# 750
Post # of 775 
I appreciate your opinion, I've made some money over the past couple years quietly following u around these boards. Thanks.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences